New Finding Could Revolutionize Cancer Treatment

A new way to keep tumor cells alive in a lab has been discovered by US researchers. This finding could transform cancer treatment.

Until now, scientists have been unable to make cancer cells thrive for very long, or in a condition that resembles the way they act in the body. Doctors diagnose and recommend treatment largely based on biopsied tissue that is frozen or set in wax.

Liver Cancer - Types, Causes, Symptoms, Diagnosis, Treatment, Prevention, Progosis
Liver or hepatic cancer is an abnormal growth of cells in the liver. The leading cause of the disease is cirrhosis or scarring of the liver tissue.

The advance has sparked new hope that someday doctors may be able to test a host of cancer-killing drugs on a person's own tumor cells in the lab, before returning to the patient with a therapy that is a proven to be a good match.

"This would really be the ultimate in personalized medicine," said lead author Richard Schlegel, chairman of the department of pathology at Georgetown University's Lombardi Comprehensive Cancer Center.

"The therapies would be exactly from their tissues. We would get normal tissue and tumor tissue from a particular patient and specifically match up their therapies," he told AFP.

Quiz on Liver
How many of us know that the liver is a vital organ the size of an American Football? To understand more about the liver and its functions spend a few minutes taking part in this quiz.

"We are really excited about the possibilities of testing we can do with this."

The method, described in the online edition of the American Journal of Pathology, borrows from a simple method used in stem cell research, experts said.

Liver Cancer Treatment
Liver Cancer is the uncontrolled growth of cells in the liver. The present section provides a graphic description of the various forms of liver cancer treatment in addition to the latest techniques such as Chemoembolisation and Radio frequency Ablation.

Lung, breast, prostate and colon cancers were kept alive for up to two years using the technique, which combines fibroblast feeder cells to keep cells alive and a Rho kinase (ROCK) inhibitor that allows them to reproduce.

When treated with the duo, both cancer and normal cells reverted to a "stem-like state," Schlegel said, allowing researchers to compare the living cells directly for the first time.

Limitations in Liver Cancer Screening Uncovered
Recent studies have uncovered the limitations in screening for primary liver cancer, also known as hepatocellular carcinoma (HCC).

If other scientists can replicate the technique -- and three labs in the United States are already working on it -- the advance could herald a long-awaited transformation in the way cancer cells are studied.

"A tumor from one patient is different from a cancer from another patient, and really that is one important reason why so many clinical trials fail," said Marc Symons, investigator at the Center for Oncology and Cell Biology at The Feinstein Institute for Medical Research in Manhasset, New York.

"I think it is fair to say this revolutionizes the way we think of cancer treatment," added Symons, who was not involved in the study.

Cancer is the leading cause of death in the world, killing 7.6 million people in 2008, according to the latest data from the World Health Organization.

Source-AFP